
HBM Healthcare Investments
56 portfolio companies · 10 on the map · $3.4B raised · 8 cities
Portfolio map
10 HBM Healthcare Investments portfolio companies on the map.
Portfolio companies

Harmony Biosciences
Plymouth Meeting
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Pharmaceutical Manufacturing$1.7BEst. 2017
Arcutis Biotherapeutics
Westlake Village
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Biotechnology Research$833.5MEst. 2016
Mineralys Therapeutics
Radnor
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Biotechnology Research$740.5MEst. 2020Hiring fast
Genalyte
San Diego
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Biotechnology$154.8MEst. 2007
1000Farmacie
Naples
1000Farmacie: #1 Italian Pharmacy and Healthcare Platform
Healthtech$24MEst. 2020CORXEL Pharmaceuticals
Berkeley Heights
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Biotechnology ResearchSeries DEst. 2019
SpringWorks Therapeutics
Stamford
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Biotechnology ResearchPublicEst. 2017
ADARx Pharmaceuticals
San Diego
ADARx Pharmaceuticals, Inc., a San Diego-based clinical-stage biotechnology company, develops RNA-targeting platforms and oligonucleotide delivery technologies to inhibit, degrade, or edit disease-causing mRNA, pursuing programs across gene
BiotechnologyEst. 2019Odyssey Therapeutics
Boston
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Biotechnology ResearchSeries DEst. 2021AnaptysBio
San Diego
AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.
Biotechnology ResearchPublicEst. 2005
More portfolio companies
44 more HBM Healthcare Investments investments we track beyond the map — 56 tracked in total.
Pyxis OncologyBoston · Series B
Fore BiotherapeuticsPhiladelphia · Series D
Everest MedicinesNew York · Series C
Dren BioFoster City · Series B
Upstream BioWaltham · Series B
SeerRedwood City · Series D
Valo HealthBoston · Series C
Neuron23San Francisco · Series D
connectRNWaltham · Venture
Galera TherapeuticsMalvern · Series C
Sphingotec GmbHHohen Neuendorf · Series C
Vicore PharmaMölndal · Post-IPO Equity
AmbrxLa Jolla · Private Equity
Molecular PartnersZürich · Post-IPO Equity
Shape Memory MedicalSanta Clara · Series C
Werewolf TherapeuticsCambridge · Series B
AdrenomedBerlin · Convertible Note
FarmalistoBogotá · Series B
1mgGurgaon · Corporate
BaseHealthSunnyvale · Series C
Fennec PharmaceuticalsDurham · Convertible Note
Sublimity TherapeuticsDublin · Series B
Connect BiopharmaceuticalsTaicang · Series C
ITeos TherapeuticsCambridge · Series B
Y-mAbs TherapeuticsNew York · Private Equity
Vascular DynamicsMountain View · Venture
ChemoCentryxSan Carlos · Series E
Instil BioDallas · Series B
Nabriva TherapeuticsVienna · Series B
Longboard PharmaceuticalsSan Diego · Series A
IVERIC bioPrinceton · Series C
Anthera PharmaceuticalsHayward · Venture
Zosano PharmaFremont · Series B
Turning Point TherapeuticsSan Diego · Private Equity
Viela BioGaithersburg · Series B
EverlifeSingapore · Series A
RenovisSouth San Francisco · Series B
AdnexusWaltham · Series C
Pelikan TechnologiesPalo Alto · Series F
Lux BiosciencesJersey City · Series B
MTM LaboratoriesHeidelberg · Series C
Cylene PharmaceuticalsSan Diego · Series D
Advanced Accelerator ApplicationsSaint-genis-pouilly · Venture
AnesivaSouth San Francisco · Series C
Portfolio map
10 HBM Healthcare Investments portfolio companies on the map.